|
Index of reports
> Cases with Hypotension ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Optimark side effects in female
Reported by a lawyer from United States on 2012-07-26
Patient: female, weighing 118.8 kg (261.4 pounds)
Reactions: Lymphadenopathy, Septic Encephalopathy, Tachycardia, Decubitus Ulcer, Upper Respiratory Tract Infection, Iron Deficiency Anaemia, Dermatitis, Graft Thrombosis, Oedema Peripheral, Pulmonary Oedema, Hyperphosphataemia, Hypertensive Heart Disease, Hypotension, Nephrogenic Systemic Fibrosis, Gene Mutation Identification Test Positive, Electrocardiogram QT Prolonged, Wheezing, Drug Interaction, Fall, Blood Bilirubin Decreased, Hyperparathyroidism, Erosive Oesophagitis, Graft Infection, Fluid Overload, Dyspnoea, Haemorrhoids, Syncope, Pericarditis, Sepsis, Sinus Disorder, Hypothyroidism, Asthma, Bronchopneumonia, Pleuritic Pain, Coagulopathy, Pulmonary Embolism, Cardiac Failure Acute, Duodenitis, Colon Adenoma, Nodule, Electrocardiogram T Wave Abnormal, Carpal Tunnel Syndrome, Abscess Limb, Pain in Extremity, Breast Calcifications, Respiratory Distress, Insomnia, Dyslipidaemia, Diverticulum Intestinal Haemorrhagic, Pain, Gastritis, Hypokalaemia, Myalgia, Neuropathy Peripheral, Pericardial RUB, Azotaemia, Gastrooesophageal Reflux Disease, Jugular Vein Thrombosis, Systemic Sclerosis, Tracheobronchitis, Migraine, Haemoptysis, Atrial Fibrillation, Renal Failure Chronic, Pneumonia Bacterial, Diarrhoea, Gastroenteritis, Protein C Deficiency, Hypertension, Superior Vena Cava Syndrome, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Optimark
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-31
End date: 2005-08-31
Gadolinium
Dosage: unk, single
Indication: Angiogram
Start date: 2004-02-06
End date: 2004-02-06
Other drugs received by patient: Nephro-Vite / 01801401 /; Guaifenesin DM; Diovan; Renagel; Lorazepam; Accupril; Azithromycin; Tylenol with Codein #3; Propoxyphene HCL; Zosyn; Albuterol; Atenolol; Epogen; Calcitriol; Lasix; Atrovent; Hydralazine HCL
Possible Optimark side effects in female
Reported by a physician from United States on 2012-05-01
Patient: female
Reactions: Abdominal Pain, Orthostatic Hypotension, Pulmonary Embolism, Osteomyelitis, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Anaemia, Hypotension, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Nail Hypertrophy, Osteopenia, Osteosclerosis, Iliac Artery Stenosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Pain, Fall, Hypoacusis, Skin Ulcer, Intervertebral Discitis, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Retroperitoneal Lymphadenopathy, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-03
End date: 2006-03-03
Multihance
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-30
End date: 2008-07-30
Gadolinium
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2010-01-01
End date: 2010-01-01
Optimark
Indication: Angiogram
Omniscan
Dosage: 40 ml, single
Indication: Angiogram
Start date: 2007-02-06
End date: 2007-02-06
Multihance
Dosage: 17 ml, single
Start date: 2009-11-19
End date: 2009-11-19
Possible Optimark side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-13
Patient: female
Reactions: Abdominal Pain, Osteomyelitis, Orthostatic Hypotension, Pulmonary Embolism, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Hypotension, Anaemia, Nail Hypertrophy, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Fall, Hypoacusis, Intervertebral Discitis, Skin Ulcer, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Multihance
Dosage: 17 ml, single
Start date: 2009-11-19
End date: 2009-11-19
Optimark
Dosage: unk, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-03
End date: 2006-03-03
Optimark
Indication: Angiogram
Omniscan
Dosage: 40 ml, single
Indication: Angiogram
Start date: 2007-02-06
End date: 2007-02-06
Multihance
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-30
End date: 2008-07-30
Gadolinium
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2010-01-01
End date: 2010-01-01
|
